
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Sun Pharma reported Q4 FY26 net profit of ₹2,714 crore and revenue around ₹14,560–14,612 crore, while recommending a ₹5 final dividend and reporting a 27.1% EBITDA margin.
Gujarat Industries Power Company (GIPCL) outlined multiple board meeting dates for FY26 results reviews, trading-window closure timelines, and FY25 dividend and AGM schedule disclosures.
Stock market today: Nifty climbed above 23,700 and Sensex rose 232 points as oil cooled and banks led, though benchmarks faded from highs.
Retail algo traders compare Indian broker APIs on WebSocket drops, token expiry, and latency spikes at 9:15 am and expiry days, focusing on stability over averages.
Safari and VIP shares are down in 2026, but analysts stay more positive on Safari after recent results, technical levels, and expectations of margin recovery as input costs ease.
Ganesha Ecosphere reported Q4 FY26 consolidated revenue of ₹423.9 crore and net profit of ₹23.2 crore, with EBITDA margin at 12.4% and sharp QoQ improvement.
Arihant Capital Markets reported standalone March 2026 net sales of ₹50.92 crore, up 12.19% year-on-year, while recent consolidated data showed softer growth trends.
Mufin Green Finance reported higher FY26 profit and revenue, improved asset-quality ratios, and fresh funding via NCDs and a USDFC loan, while valuations remain rich.
Sandhar Technologies hit a 52-week high after strong Q4FY26 earnings, with operating income up 29% YoY and PAT rising 50%, while the board explored electronics partnerships.
Sun TV Network shares fell about 6% after Q4FY26 profit dropped 37% YoY and revenue slipped 6%, as ad weakness and one-offs hit margins.
Page Industries reported a 9% rise in Q4 FY26 profit and declared a fourth interim dividend of ₹150 per share, with May 27, 2026 as the record date.
SEBI has appointed BDO India Services to run a forensic audit of Elitecon International’s accounts for FY2022-23 to FY2025-26 after an interim order citing alleged misleading disclosures.
Jubilant Pharmova posted a Q4 FY25 profit turnaround on higher revenue and stronger EBITDA margins, with growth led by radiopharma and CDMO sterile injectables.
RateGain jumped up to 13% after reporting record Q4FY26 revenue of ₹716 crore, while Sheela Foam and Ashapura Minechem also gained in a broad market rally.
Zen Technologies’ stock moved sharply on AI anti-drone and laser system updates, a ₹1,000-crore order outlook, MoD contracts, and a UAV entry via TISA Aerospace, amid uneven results.
Healthcare Global Enterprises has outlined a five-year expansion plan spanning brownfield and greenfield projects, 10 LINAC additions, and margin and ROCE targets backed by ₹600-700 crore capex.